Search Articles

View query in Help articles search

Search Results (1 to 10 of 1428 Results)

Download search results: CSV END BibTex RIS


Effect of Early Treatment of Spasticity After Stroke on Motor Recovery: Protocol for the Baclotox Multicenter, Double-Blind, Double-Dummy Randomized Controlled Trial

Effect of Early Treatment of Spasticity After Stroke on Motor Recovery: Protocol for the Baclotox Multicenter, Double-Blind, Double-Dummy Randomized Controlled Trial

Baclofen is a GABA (γ-aminobutyric acid)-B agonist that reduces spasticity by enhancing presynaptic inhibition, thereby decreasing the excitability of afferents in spinal reflexes. Despite its widespread use and endorsement by the French National Health Authority, Haute Autorité de Santé, as a first-line treatment, studies in animal models have raised concerns about the impact of GABAergic drugs on motor recovery.

Emmeline Montane, Nabila Brihmat, Camille Cormier, Claire Thalamas, Vanessa Rousseau, Gerard Tap, Xavier De Boissezon, Evelyne Castel-Lacanal, Baclotox Group, Philippe Marque

JMIR Res Protoc 2025;14:e62951

Fine-Grained Classification of Pressure Ulcers and Incontinence-Associated Dermatitis Using Multimodal Deep Learning: Algorithm Development and Validation Study

Fine-Grained Classification of Pressure Ulcers and Incontinence-Associated Dermatitis Using Multimodal Deep Learning: Algorithm Development and Validation Study

Confusion matrices showing the best benchmarks for different classification tasks: (a) binary classification, (b) pressure ulcer (PU) category, and (c) incontinence-associated dermatitis (IAD) category. To evaluate our model’s performance, we conducted a comparative analysis against the initial hospital inputs recorded in the primary hospital systems, as well as the annotation performance of 2 wound experts and a health care provider without extensive wound expertise on the test dataset.

Alexander Brehmer, Constantin Seibold, Jan Egger, Khalid Majjouti, Michaela Tapp-Herrenbrück, Hannah Pinnekamp, Vanessa Priester, Michael Aleithe, Uli Fischer, Bernadette Hosters, Jens Kleesiek

JMIR AI 2025;4:e67356

The Comprehensive Adaptive Multisite Prevention of University Student Suicide Trial: Protocol for a Randomized Controlled Trial

The Comprehensive Adaptive Multisite Prevention of University Student Suicide Trial: Protocol for a Randomized Controlled Trial

The primary goal of aim 1 is to identify the most effective ATS among the 4 embedded strategies (A+B, A+C, D+E, or D+F, as shown in Table 2) that leads to the greatest reduction in STB. This aim focuses on finding the best-performing ATS rather than testing a hypothesis. The sample size of 480 was found to ensure an 80% probability of correctly identifying the ATS with the lowest mean outcome, assuming that such a strategy exists.

Kyla Blalock, Jacqueline Pistorello, Shireen L Rizvi, John R Seeley, Francesca Kassing, James Sinclair, Linda A Oshin, Robert J Gallop, Cassidy M Fry, Ted Snyderman, David A Jobes, Jennifer Crumlish, Hannah R Krall, Susan Stadelman, Filiz Gözenman-Sapin, Kate Davies, David Steele, David B Goldston, Scott N Compton

JMIR Res Protoc 2025;14:e68441